Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial

NCT02373124 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Cocaine Use Disorders

Interventions

DRUG: infusion of NMDA antagonist

Sponsor

New York State Psychiatric Institute